ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Scintimun, Markierungsbesteck:b.e.imaging.ag
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
V09HA03 - Technetium (99mtc) Antigranulocyte AntibodyATC-DDD Version 2016. Source: WHO
V - Various
 

This group comprises many different types of drugs, and assigning DDDs are difficult. Very few DDDs are assigned in this group.

V09 - Diagnostic Radiopharmaceuticals
 

No DDDs have been assigned for radiopharmaceuticals.

V09H - Inflammation and Infection Detection

This group comprises agents for the detection of inflammation and infection. Labelled blood cells are classified in this group. Agents that are used for the labelling of these cells can also be classified elsewhere, e.g. technetium-exametazime is classified in V09A - Central Nervous System. No subdivision is made for the type of labelled cells (erythrocytes, granulocytes or autologous etc.).

V09HA - Technetium (99mtc) Compounds
 
V09HA03 - Technetium (99mtc) Antigranulocyte Antibody
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home